Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Safety and Health Research Member Conflict Review, Program Announcement Number (PA) 04-038, 8386 [E7-3184]

Download as PDF 8386 Federal Register / Vol. 72, No. 37 / Monday, February 26, 2007 / Notices There is no cost to respondents other than their time. ESTIMATE OF ANNUALIZED BURDEN HOURS Respondents (type of form) Number of respondents Frequency of response Average time per response Annual burden (in hours) New Enrollees .......................................................................................... Laboratory Change Form ........................................................................ Laboratory Test Result Form ................................................................... 100 20 754 1 1 2 3/60 3/60 10/60 5 1 251 Total .................................................................................................. .......................... .......................... .......................... 257 Dated: February 20, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–3167 Filed 2–23–07; 8:45 am] BILLING CODE 4163–18–P Dated: February 20, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–3184 Filed 2–23–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institutes of Health Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Safety and Health Research Member Conflict Review, Program Announcement Number (PA) 04–038 ycherry on PROD1PC64 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Meeting of the aforementioned committee: Time and Date: 1 p.m.–4 p.m., March 14, 2007 (Closed). Place: National Institute for Occupational Safety and Health, 626 Cochrans Mill Road, Pittsburgh, PA 15236. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to PA 04–038, ‘‘Occupational Safety and Health Research Member Conflict Review.’’ Contact Person for More Information: George Bockosh, Designated Federal Officer, National Institute for Occupational Safety and Health, 626 Cochrans Mill Road, Pittsburgh, PA 30333, telephone 412.386.6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 16:03 Feb 23, 2007 Jkt 211001 National Eye Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Mentored Training Grant Applications (K series). Date: February 26, 2007. Time: 10 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 5635 Fishers Lane, Suite 1300, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Anne E. Schaffner, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300. (301) 451–2020, aes@nei.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Epidemiology, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Genetics and Data Analysis Grant Applications. Date: March 22, 2007. Time: 8:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Houmam H. Araj, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, NIH, 5635 Fishers Lane, Suite 1300, Bethesda, MD 20892–9602, 301–451–2020, haraj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision research, National Institutes of Health, HHS. Dated: February 15, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–831 Filed 2–23–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Biostatistical Training Program in Genetics and Public Health. Date: March 9, 2007. Time: 8 a.m. to 6 p.m. E:\FR\FM\26FEN1.SGM 26FEN1

Agencies

[Federal Register Volume 72, Number 37 (Monday, February 26, 2007)]
[Notices]
[Page 8386]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Occupational Safety and Health Research Member Conflict 
Review, Program Announcement Number (PA) 04-038

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Meeting of the aforementioned 
committee:

    Time and Date: 1 p.m.-4 p.m., March 14, 2007 (Closed).
    Place: National Institute for Occupational Safety and Health, 
626 Cochrans Mill Road, Pittsburgh, PA 15236.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in 
response to PA 04-038, ``Occupational Safety and Health Research 
Member Conflict Review.''
    Contact Person for More Information: George Bockosh, Designated 
Federal Officer, National Institute for Occupational Safety and 
Health, 626 Cochrans Mill Road, Pittsburgh, PA 30333, telephone 
412.386.6465.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 20, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-3184 Filed 2-23-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.